Literature DB >> 9146588

Anterior flap extraperitoneal cystoplasty.

M Albo1, S Raz, M C Dupont.   

Abstract

PURPOSE: We report on our initial experience with the anterior flap extraperitoneal cystoplasty for refractory voiding symptoms secondary to detrusor hyperactivity.
MATERIALS AND METHODS: A total of 27 patients underwent anterior flap extraperitoneal cystoplasty, the principles of which include a Pfannenstiel skin incision, a small peritoneotomy with minimal manipulation of the bowel, extraperitoneal bowel resection with ileovesical anastomosis and creation of an anterior bladder wall flap.
RESULTS: Convalescence was uneventful in 25 patients (92%). Oral intake resumed on postoperative day 3 or 4, and the patient was discharged home on postoperative day 5 or 6. Voiding symptoms resolved or improved significantly in 92% of patients, who were dry or used 1 or no pads a day. Two complications required prolonged hospitalization.
CONCLUSIONS: Anterior flap extraperitoneal cystoplasty is a safe and effective treatment that has the potential to decrease postoperative complications and recovery time.

Entities:  

Mesh:

Year:  1997        PMID: 9146588

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  4 in total

Review 1.  Augmentation cystoplasty: what are the indications?

Authors:  Polina Reyblat; David A Ginsberg
Journal:  Curr Urol Rep       Date:  2008-11       Impact factor: 3.092

Review 2.  Minimally Invasive Techniques for Bladder Reconstruction.

Authors:  Tony Nimeh; Sean Elliott
Journal:  Curr Urol Rep       Date:  2018-04-13       Impact factor: 3.092

3.  Comparison of extraperitoneal and intraperitoneal augmentation enterocystoplasty for neurogenic bladder in spinal cord injury patients.

Authors:  Polina Reyblat; Kevin G Chan; David Y Josephson; John P Stein; John A Freeman; Gary D Grossfeld; David Esrig; David A Ginsberg
Journal:  World J Urol       Date:  2008-11-20       Impact factor: 4.226

Review 4.  Management of the neurogenic bladder in the female patient.

Authors:  David A Ginsberg
Journal:  Curr Urol Rep       Date:  2006-09       Impact factor: 2.862

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.